Clinical trial
DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients: a Longitudinal Observational Study During a One-year Period After Transplantation - the Geneva Blood Virome Project (GeBVir)
NCT03642977 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients: a Longitudinal Observational Study During a One-year Period After Transplantation - the Geneva Blood Virome Project (GeBVir)
- Lead sponsor
- University Hospital, Geneva
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2017
- Completion date
- December 31, 2020
- Enrollment
- 112 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood virome, dna virus infections, hematopietic stem cell transplantation, rna virus infections